INS and metabolic dysfunction-associated steatotic liver disease: They are particularly effective at sensitising adipose tissue to insulin, promoting fatty acid uptake and storage [83] and this may be the pre-dominant mechanism by which they improve hepatic steatosis [84] particularly given that PPARΥ expression within the liver is increased in individuals with NAFLD [85].